Top

Published in:

Open Access 01-12-2016 | Research

Feasibility of automated proton therapy plan adaptation for head and neck tumors using cone beam CT images

Authors: Christopher Kurz, Reinoud Nijhuis, Michael Reiner, Ute Ganswindt, Christian Thieke, Claus Belka, Katia Parodi, Guillaume Landry

Published in: Radiation Oncology | Issue 1/2016

Abstract

Background

Intensity modulated proton therapy (IMPT) of head and neck (H&N) tumors may benefit from plan adaptation to correct for the dose perturbations caused by weight loss and tumor volume changes observed in these patients. As cone beam CT (CBCT) is increasingly considered in proton therapy, it may be possible to use available CBCT images following intensity correction for plan adaptation. This is the first study exploring IMPT plan adaptation on CBCT images corrected and delineated by deformable image registration of the planning CT (pCT) to the CBCT, yielding a virtual CT (vCT).

Methods

A Morphons algorithm was used to deform the pCTs and corresponding delineations of 9 H&N cancer patients to a weekly CBCT acquired within ±3 days of a control replanning CT scan (rpCT). The IMPT treatment plans were adapted using the vCT and the adapted and original plans were recalculated on the rpCT for dose/volume parameter evaluation of the impact of adaptation.

Results

On the rpCT, the adapted plans were equivalent to the original plans in terms of target volumes D ₉₅ and V ₉₅, but showed a significant reduction of D ₂ in these volumes. OAR doses were mostly equivalent or reduced. In particular, the adapted plans did not reduce parotid gland D _mean, but the dose to the optical system. For three patients the spinal cord or brain stem received higher, though well below tolerance, maximum dose. Subsequent tightening of the treatment planning constraints for these OARs on new vCT-adapted plans did not degrade target coverage and yielded pCT equivalent plans on the vCT.

Conclusions

An offline automated procedure to generate an adapted IMPT plan on CBCT images was developed and investigated. When evaluating the adapted plan on a control rpCT we observed reduced D ₂ in target volumes as major improvement. OAR sparing was only partially improved by the procedure. Despite potential limitations in the accuracy of the vCT approach, an improved quality of the adapted plans could be achieved.

Available only for authorised users

Gupta T, Hotwani C, Kannan S, Master Z, Rangarajan V, Murthy V, et al. Prospective longitudinal assessment of parotid gland function using dynamic quantitative pertechnate scintigraphy and estimation of dose-response relationship of parotid-sparing radiotherapy in head-neck cancers. Radiat Oncol. 2015;10:67. doi:10.1186/s13014-015-0371-2.CrossRefPubMedPubMedCentral

Studer G, Linsenmeier C, Riesterer O, Najafi Y, Brown M, Yousefi B, et al. Late term tolerance in head neck cancer patients irradiated in the IMRT era. Radiat Oncol. 2013;8:259. doi:10.1186/1748-717X-8-259.CrossRefPubMedPubMedCentral

Studer G, Rordorf T, Glanzmann C. Impact of tumor volume and systemic therapy on outcome in patients undergoing IMRT for large volume head neck cancer. Radiat Oncol. 2011;6:120. doi:10.1186/1748-717X-6-120.CrossRefPubMedPubMedCentral

Widesott L, Pierelli A, Fiorino C, Dell'oca I, Broggi S, Cattaneo GM, et al. Intensity-modulated proton therapy versus helical tomotherapy in nasopharynx cancer: planning comparison and NTCP evaluation. Int J Radiat Oncol Biol Phys. 2008;72(2):589–96. doi:10.1016/j.ijrobp.2008.05.065.CrossRefPubMed

Simone 2nd CB, Ly D, Dan TD, Ondos J, Ning H, Belard A, et al. Comparison of intensity-modulated radiotherapy, adaptive radiotherapy, proton radiotherapy, and adaptive proton radiotherapy for treatment of locally advanced head and neck cancer. Radiother Oncol. 2011;101(3):376–82. doi:10.1016/j.radonc.2011.05.028.CrossRefPubMedPubMedCentral

van de Water TA, Lomax AJ, Bijl HP, de Jong ME, Schilstra C, Hug EB, et al. Potential benefits of scanned intensity-modulated proton therapy versus advanced photon therapy with regard to sparing of the salivary glands in oropharyngeal cancer. Int J Radiat Oncol Biol Phys. 2011;79(4):1216–24. doi:10.1016/j.ijrobp.2010.05.012.CrossRefPubMed

van der Laan HP, van de Water TA, van Herpt HE, Christianen ME, Bijl HP, Korevaar EW, et al. The potential of intensity-modulated proton radiotherapy to reduce swallowing dysfunction in the treatment of head and neck cancer: A planning comparative study. Acta Oncol. 2013;52(3):561–9. doi:10.3109/0284186X.2012.692885.CrossRefPubMed

Jakobi A, Bandurska-Luque A, Stützer K, Haase R, Löck S, Wack LJ, et al. Identification of Patient Benefit From Proton Therapy for Advanced Head and Neck Cancer Patients Based on Individual and Subgroup Normal Tissue Complication Probability Analysis. Int J Radiat Oncol Biol Phys. 2015;92(5):1165–74. doi:10.1016/j.ijrobp.2015.04.031.CrossRefPubMed

Kraan AC, van de Water S, Teguh DN, Al-Mamgani A, Madden T, Kooy HM, et al. Dose uncertainties in IMPT for oropharyngeal cancer in the presence of anatomical, range, and setup errors. Int J Radiat Oncol Biol Phys. 2013;87(5):888–96. doi:10.1016/j.ijrobp.2013.09.014.CrossRefPubMed

10.

Góra J, Kuess P, Stock M, Andrzejewski P, Knäusl B, Paskeviciute B, et al. ART for head and neck patients: On the difference between VMAT and IMPT. Acta Oncol. 2015;54(8):1166–74. doi:10.3109/0284186X.2015.1028590.CrossRefPubMed

11.

Müller BS, Duma MN, Kampfer S, Nill S, Oelfke U, Geinitz H, et al. Impact of interfractional changes in head and neck cancer patients on the delivered dose in intensity modulated radiotherapy with protons and photons. Phys Medica. 2015;31(3):266–72. doi:10.1016/j.ejmp.2015.02.007.CrossRef

12.

Park S, Cho M, Kim H. On-board CBCT/CBDT for Image-guided Proton Therapy: Initial Performance Evaluation. Int J Radiat Oncol Biol Phys. 2009;75(Supplement Issue 3):S595–6. doi:10.1016/j.ijrob.2009.07.1361.CrossRef

13.

Kurz C, Dedes G, Resch A, Reiner M, Ganswindt U, Nijhuis R, et al. Comparing cone-beam CT intensity correction methods for dose recalculation in adaptive intensity-modulated photon and proton therapy for head and neck cancer. Acta Oncol. 2015;54(9):1651–7. doi:10.3109/0284186X.2015.1061206.CrossRefPubMed

14.

Siewerdsen JH, Jaffray DA. Cone-beam computed tomography with a flat-panel imager: magnitude and effects of x-ray scatter. Med Phys. 2001;28(2):220–31. doi: http://dx.doi.org/10.1118/1.1339879.CrossRefPubMed

15.

Fotina I, Hopfgartner J, Stock M, Steininger T, Lütgendorf-Caucig C, Georg D. Feasibility of CBCT-based dose calculation: comparative analysis of HU adjustment techniques. Radiother Oncol. 2012;104(2):249–56. doi:10.1016/j.radonc.2012.06.007.CrossRefPubMed

16.

Zhang T, Chi Y, Meldolesi E, Yan D. Automatic delineation of on-line head-and-neck computed tomography images: toward on-line adaptive radiotherapy. Int J Radiat Oncol Biol Phys. 2007;68(2):522–30. doi:10.1016/j.ijrobp.2007.01.038.CrossRefPubMed

17.

Wu Q, Chi Y, Chen PY, Krauss DJ, Yan D, Martinez A. Adaptive replanning strategies accounting for shrinkage in head and neck IMRT. Int J Radiat Oncol Biol Phys. 2009;75(3):924–32. doi:10.1016/j.ijrobp.2009.04.047.CrossRefPubMed

18.

Peroni M, Ciardo D, Spadea MF, Riboldi M, Comi S, Alterio D, et al. Automatic segmentation and online virtualCT in head-and-neck adaptive radiation therapy. Int J Radiat Oncol Biol Phys. 2012;84(3):e427–33. doi:10.1016/j.ijrobp.2012.04.003.CrossRefPubMed

19.

Zhen X, Gu X, Yan H, Zhou L, Jia X, Jiang SB. CT to cone-beam CT deformable registration with simultaneous intensity correction. Phys Med Biol. 2012;57(21):6807–26. doi:10.1088/0031-9155/57/21/6807.CrossRefPubMedPubMedCentral

20.

Zhen X, Yan H, Zhou L, Jia X, Jiang SB. Deformable image registration of CT and truncated cone-beam CT for adaptive radiation therapy. Phys Med Biol. 2013;58(22):7979–93. doi:10.1088/0031-9155/58/22/7979.CrossRefPubMed

21.

Veiga C, McClelland J, Moinuddin S, Lourenço A, Ricketts K, Annkah J, et al. Toward adaptive radiotherapy for head and neck patients: Feasibility study on using CT-to-CBCT deformable registration for “dose of the day” calculations. Med Phys. 2014;41(3):031703. doi:10.1118/1.4864240.CrossRefPubMed

22.

Landry G, Dedes G, Zöllner C, Handrack J, Janssens G. Orban de Xivry J et al. Phantom based evaluation of CT to CBCT image registration for proton therapy dose recalculation. Phys Med Biol. 2015;60(2):595–613. doi:10.1088/0031-9155/60/2/595.CrossRefPubMed

23.

Landry G, Nijhuis R, Dedes G, Handrack J, Thieke C, Janssens G, et al. Investigating CT to CBCT image registration for head and neck proton therapy as a tool for daily dose recalculation. Med Phys. 2015;42(3):1354–66. doi:10.1118/1.4908223.CrossRefPubMed

24.

Thomson DJ, Teo B-KK, Ong A, Ang KW, Kirk M, Ahn PH, et al. The Impact of Anatomic Change on Pencil Beam Scanning in the Treatment of Oropharynx Cancer. Int J Part Ther. 2015;2(2):394–403. doi:10.14338/IJPT-15-00002.1.CrossRef

25.

Veiga C, Alshaikhi J, Amos R, Lourenco AM, Modat M, Ourselin S, et al. Cone-beam computed tomography and deformable registration-based “dose of the day” calculations for adaptive proton therapy. Int J Part Ther. 2015;2(2):404–14. doi:10.14338/IJPT-14-00024.1.CrossRef

26.

Veiga C, Janssens G, Teng C-L, Baudier T, Hotoiu L, McClelland JR, et al. First clinical investigation of CBCT and deformable registration for adaptive proton therapy of lung cancer. Int J Radiat Oncol Biol Phys. 2016. doi: http://dx.doi.org/10.1016/j.ijrobp.2016.01.055.

27.

Hardcastle N, Tomé WA, Cannon DM, Brouwer CL, Wittendorp PW, Dogan N, et al. A multi-institution evaluation of deformable image registration algorithms for automatic organ delineation in adaptive head and neck radiotherapy. Radiat Oncol. 2012;7:90. doi:10.1186/1748-717X-7-90.CrossRefPubMedPubMedCentral

28.

Grégoire V, Eisbruch A, Hamoir M, Levendag P. Proposal for the delineation of the nodal CTV in the node-positive and the post-operative neck. Radiother Oncol. 2006;79(1):15–20. doi:10.1016/j.radonc.2006.03.009.CrossRefPubMed

29.

Janssens G, de Xivry JO, Fekkes S, Dekker A, Macq B, Lambin P, et al. Evaluation of nonrigid registration models for interfraction dose accumulation in radiotherapy. Med Phys. 2009;36(9):4268–76. doi: http://dx.doi.org/10.1118/1.3194750.CrossRefPubMed

30.

Breedveld S, Storchi PR, Keijzer M, Heemink AW, Heijmen BJ. A novel approach to multi-criteria inverse planning for IMRT. Phys Med Biol. 2007;52(20):6339–53. doi:10.1088/0031-9155/52/20/016.CrossRefPubMed

31.

Holliday EB, Frank SJ. Proton radiation therapy for head and neck cancer: a review of the clinical experience to date. Int J Radiat Oncol Biol Phys. 2014;89(2):292–302. doi:10.1016/j.ijrobp.2014.02.029.CrossRefPubMed

Title: Feasibility of automated proton therapy plan adaptation for head and neck tumors using cone beam CT images
Authors: Christopher Kurz
Reinoud Nijhuis
Michael Reiner
Ute Ganswindt
Christian Thieke
Claus Belka
Katia Parodi
Guillaume Landry
Publication date: 01-12-2016
Publisher: BioMed Central
Published in: Radiation Oncology / Issue 1/2016
Electronic ISSN: 1748-717X
DOI: https://doi.org/10.1186/s13014-016-0641-7

ACC 2024 Congress

Springer Medicine

Feasibility of automated proton therapy plan adaptation for head and neck tumors using cone beam CT images

Abstract

Background

Methods

Results

Conclusions

ACC 2024 Congress

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2016

Efficacy and feasibility of ambulatory treatment-based monthly nedaplatin plus S-1 in definitive or salvage concurrent chemoradiotherapy for early, advanced, and relapsed esophageal cancer

Variable RBE in proton therapy: comparison of different model predictions and their influence on clinical-like scenarios

Biological modelling of the radiation dose escalation effect of regional hyperthermia in cervical cancer

The dosimetric impact of implants on the spinal cord dose during stereotactic body radiotherapy

Challenges in radiobiological modeling: can we decide between LQ and LQ-L models based on reviewed clinical NSCLC treatment outcome data?

Overall survival after reirradiation of spinal metastases – independent validation of predictive models